在非囊性纤维化支气管切除症的成年人中修改后的增量步骤试验的临床决定因素
Melike Mese Buran1, Sema Savci2, Aylin Tanriverdi3
1. Graduate School of Health Sciences, Dokuz Eylül University, Izmir, Turkey.
概括
疾病的严重程度,肌肉强度,体力活动和生活质量决定了非囊性纤维化支气管病 (NCFB) 患者的运动能力,这些患者使用了修改后的增量步骤测试 (MIST). MIST提供了一个比增量穿步行测试 (ISWT) 更强大的心肺反应.
科学领域:
- 肺部医学 肺部医学
- 运动生理学 运动生理学
- 临床研究 临床研究
背景情况:
- 非囊性纤维化支气管炎 (NCFB) 是一种慢性呼吸道疾病,影响运动能力.
- 基于现场的最大运动测试对于评估NCFB中的功能状态至关重要.
- 修改增量步骤测试 (MIST) 和增量穿步行测试 (ISWT) 是常用的,但需要进行比较分析.
研究的目的:
- 在NCFB的成年人中,通过修改增量步骤测试 (MIST) 测量运动能力的临床决定因素.
- 在NCFB患者中比较MIST和ISWT之间的心肺反应.
主要方法:
- 一项涉及46名临床稳定的NCFB患者的横截面研究.
- 使用MIST和ISWT评估运动能力.
- 评估疾病的严重程度 (支气管炎症严重程度指数),疲劳 (疲劳严重程度量表),生活质量 (圣乔治呼吸问卷),四头骨强度,步行速度和每日体力活动 (步计).
主要成果:
- MIST的变异是由疾病严重程度,四头肌强度,每日步数和生活质量 (R2 = 0.67) 解释的.
- 在MIST表现和BSI,四头肌强度,每日步数,步行速度,FSS和SGRQ分数之间发现了显著的相关性.
- 与ISWT相比,MIST引起了较高的心率,呼吸不全和腿部疲劳 (p < 0.05).
结论:
- 临床因素包括疾病严重程度,四头肌强度,身体活动水平和生活质量是NCFB中MIST表现的关键决定因素.
- 与ISWT相比,MIST显示出更好的心肺反应.
- MIST的可移植性和有效性使其成为评估NCFB患者症状有限运动能力的首选工具.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Cystic Fibrosis: Pathogenesis
239
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
239
Cystic Fibrosis: Management
164
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
164
Pulmonary Function Tests
330
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
330
Physical Assessment of the Respiratory Tract II: Inspection
291
Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration...
Chest Configuration
The chest configuration...
291


